MonicaKhungerMD

Internal Medicine • Pittsburgh, PA

Hematology/Oncology

Medical Oncologist and Hematologist

Join to view full profile

Dr. Khunger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khunger's full profile

Already have an account?

Office
5115 Centre Ave
Pittsburgh, PA 15232
Phone+1 412-235-1020

Summary

Breast and GI Medical Oncologist

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2018 - 2021
Cleveland Clinic FoundationResidency, Internal Medicine, 2018
All India Institute of Medical SciencesClass of 2014

Certifications & Licensure

PA State Medical License 2018 - 2026
OH State Medical License 2015 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

ASCO Merit Award American Society of Clinical Oncology, 2016

Publications & Presentations

PubMed

1 citations
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine.
Ibrahim Halil Sahin, Turcin Saridogan, Ruveyda Ayasun, Masood Pasha Syed, Vikram Gorantla
JCO Oncology Practice. 2024-10-01
7 citations
Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future.
Ibrahim Halil Sahin, Janie Zhang, Turcin Saridogan, Vikram Gorantla, John Rhree
JCO Oncology Practice. 2023-05-01
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer...
Monica K Malhotra, Shalu Pahuja, Brian F Kiesel, Leonard J Appleman, Fei Ding
Breast Cancer Research and Treatment. 2023-04-01

Lectures

Tumor PD-L1 heterogeneity in non-small cell lung cancer: Does biopsy size and volume matter?
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

Radiomics Can Predict Chemo Response Rate in Lung CancerApril 8th, 2019
AI Predicts How NSCLC Patients Will Respond to ChemotherapyMarch 21st, 2019
Researchers Use Radiomics to Predict Who Will Benefit from ChemotherapyMarch 20th, 2019
Join now to see all